# Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion

> **NCT07507214** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Florida** · enrollment: 35 (estimated)

## Conditions studied

- Concussion
- Depression

## Interventions

- **DEVICE:** ONE-D TMS protocol and d-cycloserine (125 mg)

## Key facts

- **NCT ID:** NCT07507214
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07507214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07507214, "Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07507214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*